Results 291 to 300 of about 749,882 (394)

Considerations for drug trials in hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant, Matthias Schmitt, Anna B. Reid, Clifford J. Garratt, William G. Newman, Aneil Malhotra, Rhys Beynon, Masliza Mahmod, Betty Raman, Robert M. Cooper, Dana Dawson, Thomas Green, Sanjay K. Prasad, Anvesha Singh, Susanna Dodd, Hugh Watkins, Stefan Neubauer, Christopher A. Miller   +17 more
wiley   +1 more source

Laparoscopic right hepatectomy for hepatocellular carcinoma after sequential yttrium-90 liver radioembolization and liver venous deprivation (with video). [PDF]

J Minim Invasive Surg
De Mathelin P, Addeo P.
europepmc   +1 more source

SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy

Circulation, 2017
Xiaoqiang Tang, Xiao-Feng Chen, Nan-Yu Wang, Xiao-Man Wang, Shu-ting Liang, Wei Zheng, Yun-biao Lu, Xiang Zhao, D. Hao, Zhu-qin Zhang, M. Zou, De-Pei Liu, Houzao Chen   +12 more
semanticscholar   +1 more source

A phenomap of TTR amyloidosis to aid diagnostic screening

ESC Heart Failure, Volume 12, Issue 2, Page 1113-1118, April 2025.
Abstract Cardiac amyloidosis due to transthyretin (ATTR) remains an underdiagnosed cause of cardiomyopathy. As awareness of the disease grows and referrals for ATTR increase, clinicians are likely to encounter more atypical forms of the condition in clinical practice.
Alexios S. Antonopoulos, Theodoros Tsampras, George Lazaros, Konstantinos Tsioufis, Charalambos Vlachopoulos   +4 more
wiley   +1 more source

Tectorigenin attenuates cardiac hypertrophy via USP9X/MCL1-mediated mitochondrial stabilization. [PDF]

Redox Biol
Chen X, Zhou G, Yuan T, He Z, Su L, Guo H, Liang F, Cai L, Li S, Yang W.   +9 more
europepmc   +1 more source

Heart failure in two male patients with late‐onset Fabry mutation (IVS4 + 919G > A)

ESC Heart Failure, Volume 12, Issue 2, Page 1508-1513, April 2025.
Xufei Yang, Chunlan Deng, Xiaogang Guo, Hui Yan   +3 more
wiley   +1 more source

Connecting the dots: A narrative review of the relationship between heart failure and cognitive impairment

ESC Heart Failure, Volume 12, Issue 2, Page 1119-1131, April 2025.
Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi, Maria Giulia Bellicini, Marianna Adamo, Andrea Pilotto, Marco Metra, Alessandro Padovani, Riccardo Proietti   +6 more
wiley   +1 more source

Targeting Cardiomyocyte PCNA and POLD1 Prevents Pathologic Myocardial Hypertrophy. [PDF]

Circ Res
Pal S, Glennon MS, Nixon BR, Chetkof EJ, Shridhar P, Kathiresan CM, Glasser MB, Waldron CJ, Guo L, Clavere NG, Banerjee D, Kim JH, Becker JR.   +12 more
europepmc   +1 more source

Electrocardiogram and Vectorcardiogram in Right Ventricular Hypertrophy and Right Bundle-Branch Block

, 1957
William R. Milnor, Charles Bertrand, Frederick Mugler   +2 more
openalex   +1 more source

Adipose tissue fibrosis, hypertrophy, and hyperplasia: Correlations with diabetes in human obesity

Obesity, 2016
Lindsey A. Muir, C. Neeley, Kevin A. Meyer, Nicki A. Baker, Alice M. Brosius, Alexandra R. Washabaugh, Oliver A. Varban, Jonathan F. Finks, B. Zamarron, C. Flesher, Joshua S. Chang, Jennifer B. Delproposto, L. Geletka, Gabriel Martinez-Santibanez, N. Kaciroti, C. Lumeng, R. O’Rourke   +16 more
semanticscholar   +1 more source